Crossmark Global Holdings’s Dynavax Technologies DVAX Stock Holding History

Crossmark Global Holdings’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,086	Closed	-$171K	–	1252
2025 Q4	$171K	Buy	+11,086	New	+$122K	﹤0.01%	1196

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Crossmark Global Holdings's DVAX Position: Q1 2026 in Review

Crossmark Global Holdings sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 11,086 shares — an estimated $171K sold.

Crossmark Global Holdings first reported a position in DVAX in Q4 2025 and held it in 1 quarter. The position peaked at $171K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Crossmark Global Holdings reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Crossmark Global Holdings sold 11,086 Dynavax Technologies shares in Q1 2026, an estimated $171K.
Crossmark Global Holdings first reported a position in Dynavax Technologies in Q4 2025 and held it in 1 quarter.
Crossmark Global Holdings's Dynavax Technologies position peaked at $171K in Q4 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Crossmark Global Holdings's 13F filing for Q1 2026, filed 11 May 2026.